Toll free: 1-855 542-5672 (1-855-KICK-MSA)

*NEW* RESEARCH UPDATE FROM BIOHAVEN RE: VERDIPERSTAT (BHV-3241)

Published by defeatmsa

May 19, 2021

Timeline: International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy

“Top line results from the study are expected to be available in 3rd Quarter of 2021 and will help to characterize the potential benefits and risks of Verdiperstat in MSA. After the study results are available, Biohaven will provide further updates on the development of Verdiperstat for the treatment of MSA.”

For information on the Mechanism of Action (MOA), please click below to access a video explaining Verdiperstat:

CLICK HERE TO DOWNLOAD UPDATE FROM BIOHAVEN MAY 2021

CLICK BELOW TO VIEW VIDEO ON VERDIPERSTAT FROM BIOHAVEN:

 

You May Also Like…

4 Comments

  1. Valerie Schuler

    When will verdiperstat be available for purchase?

    Reply
  2. Sunny Nguyen

    When Is Verdiperstat Drugs available for MSA treatment?

    Reply
    • defeatmsa

      We do not know. Biohaven, the company producing it will make an announcement about the drug trial results at the end of September or October. After that, if the result is good, the company will apply to the US government for approval. Stay up to date on research by registering on our research hub: https://defeatmsa.org/research-registry/

      Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Copy link
Powered by Social Snap